Pharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Ipratropium Bromide, and what substitute generic drugs are available?

Ipratropium Bromide is a drug marketed by Sun Pharma Global, Bausch And Lomb, Pharmascience Inc, Actavis Mid Atlantic, Teva Pharms Usa, Bausch And Lomb Inc, Apotex Inc, Aurobindo Pharma Ltd, Mylan Speclt, Nephron, West-ward Pharms Int, Roxane, Landela Pharm, Watson Labs, and Ritedose Corp. and is included in twenty-one NDAs.

The generic ingredient in IPRATROPIUM BROMIDE is ipratropium bromide. There are seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.

Summary for Tradename: IPRATROPIUM BROMIDE

Suppliers / Packagers: see list19
Bulk Api Vendors: see list60
Clinical Trials: see list109
Patent Applications: see list5,046
Formulation / Manufacturing:see details
Drug Prices:see details

Pharmacology for Tradename: IPRATROPIUM BROMIDE

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
ipratropium bromide
SOLUTION;INHALATION207903-001Jan 3, 2017RXNoNo► Subscribe► Subscribe
Landela Pharm
ipratropium bromide
SOLUTION;INHALATION077072-001Jul 19, 2005RXNoNo► Subscribe► Subscribe
Bausch And Lomb Inc
ipratropium bromide
SOLUTION;INHALATION075835-001Oct 15, 2001RXNoNo► Subscribe► Subscribe
Actavis Mid Atlantic
ipratropium bromide
SOLUTION;INHALATION075111-001Apr 22, 1999DISCNNoNo► Subscribe► Subscribe
Mylan Speclt
ipratropium bromide
SOLUTION;INHALATION074755-001Jan 10, 1997DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.